Peking University People's Hospital
776
136
155
142
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.8%
14 terminated/withdrawn out of 776 trials
91.0%
+4.5% vs industry average
11%
86 trials in Phase 3/4
4%
5 of 142 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (776)
Real-world Study of Aflibercept 8 mg in nAMD
Role: lead
TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.
Role: collaborator
Non-Contrast Breast MRI Diagnosis and Risk Stratification Using DWI-Generated Synthetic Contrast Enhancement
Role: lead
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
Role: lead
A Study of DA-302168S in Participants With Overweight/Obesity
Role: collaborator
Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia
Role: lead
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Role: lead
Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in Patients With Extreme Glucose Metabolism Phenotypes
Role: lead
Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
Role: lead
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Role: lead
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
Role: lead
Light and Anesthesia
Role: lead
Management of Age-Related Auditory Decline and Early Warning of Its Co-occurring Dementia
Role: collaborator
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma
Role: collaborator
Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Role: lead
ATRA for Management of Primary ITP
Role: lead
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
Role: lead
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Role: collaborator